Composite metal oxide and preparation method and application thereof
CN119500125APending Publication Date: 2025-02-25GUANGDONG INST FOR DRUG CONTROL (GUANGDONG INST FOR DRUG QUALITY GUANGDONG PORT DRUG CONTROL INST)
Patent Information
- Application Number
- CN202411383656.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-30
- Publication Date
- 2025-02-25
AI Technical Summary
Technical Problem
Existing technologies are insufficient to effectively remove parvoviruses from blood products, and traditional methods may affect the medicinal value of raw plasma.
Method used
A composite metal oxide (silver peroxide and manganese dioxide) was prepared by combining ultraviolet light with a silver source, potassium permanganate and a strong reducing agent solution on the surface of a substrate material. This composite metal oxide was then used to inactivate parvovirus.
Benefits of technology
It achieves highly efficient inactivation of parvoviruses, increasing the removal rate by 4-5 logarithmic levels, without affecting the raw plasma components, and is low in cost and easy to operate.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure CN119500125A_ABST
Abstract
The invention discloses a composite metal oxide. The composite metal oxide is composed of silver peroxide and manganese dioxide. The composite metal oxide disclosed by the invention can be used as a catalyst to realize continuous and efficient inactivation of parvoviruses in blood products in combination with ultraviolet rays, and the catalyst prepared by the invention can be used for improving the parvovirus load removal rate by 4-5 logarithmic levels, that is, the parvoviruses can be completely removed and inactivated when the parvovirus load in raw material plasma does not exceed 10 < 5 > Copies / mL. The method for inactivating the parvovirus by combining the catalyst with ultraviolet rays does not need to adjust pH and add soluble chemical substances, so that the components of raw material plasma are not influenced, the application cost is low, the operation is simple and convenient, and the method has a wide application prospect.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Nanometer membrane filtration system and application of nanometer membrane filtration system to removal of viruses in products
CN106823541A
Inactivation device and inactivation method for riboflavin photochemical blood product
CN110974984A
Virus removing and filtering method of in-situ sterilization nano-film
CN116251476A
Method for inactivating non-fat enveloped virus in protein solution
CN116407652A